Please write a SOAP note for a routine tuberculin skin test (PPD) read at 48‑72 hours with 0 mm induration (negative) in an asymptomatic adult without prior TB exposure or immunosuppression.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SOAP Note for Negative Tuberculin Skin Test Reading

Subjective

  • Patient presents for tuberculin skin test (TST) reading, placed [X] hours ago
  • No symptoms of active tuberculosis (no cough, fever, night sweats, weight loss, hemoptysis)
  • No known recent TB exposure
  • No history of prior positive TST
  • [Document BCG vaccination history if applicable]
  • [Document risk factors: HIV status, immunosuppression, country of origin, occupation, congregate settings]

Objective

  • TST reading performed at 48-72 hours post-placement 1, 2
  • Induration measured by palpation: 0 mm (transverse diameter)
  • Erythema only, if present, is not considered in interpretation 3
  • No vesiculation or ulceration noted
  • Vital signs: [if obtained]
  • General appearance: Well-appearing, no acute distress

Assessment

Negative tuberculin skin test (0 mm induration)

The interpretation of this negative result depends critically on the patient's risk stratification 1, 2:

  • For patients requiring ≥5 mm cutoff (HIV+, recent TB contact, prior TB on chest X-ray, TNF-blocker therapy): This is a negative result, but consider false-negative if immunosuppressed 1, 4
  • For patients requiring ≥10 mm cutoff (recent immigrants from high-prevalence countries, injection drug users, healthcare workers, residents of congregate settings): This is a negative result
  • For patients requiring ≥15 mm cutoff (no risk factors): This is a negative result

Important caveats for false-negative results 1, 4:

  • False-negatives occur more frequently in: HIV infection (strongest association, aOR 4.65-5.05), chronic renal failure, alcohol/drug abuse, age ≥65 years, early infection (<6-8 weeks post-exposure), recent viral vaccination, overwhelming TB disease, high-dose corticosteroids, TNF inhibitors
  • If clinical suspicion remains high despite negative TST, consider repeat testing in 1-2 weeks (booster phenomenon) or interferon-gamma release assay (IGRA)

Plan

  1. No treatment indicated for latent TB infection given negative result
  2. Document result as 0 mm induration at [48-72] hours
  3. If high-risk exposure or immunosuppression: Consider repeat TST in 8-10 weeks if recent exposure, or IGRA testing if immunosuppressed 1
  4. Patient education: Explained negative result means no evidence of TB infection at this time; advised to report any TB symptoms (persistent cough >3 weeks, fever, night sweats, weight loss)
  5. Follow-up: Routine unless symptoms develop or new TB exposure occurs
  6. For occupational health: Document for annual screening records; next TST per facility protocol (typically annual for healthcare workers)

Note on technique verification: TST was properly administered via Mantoux method (0.1 mL of 5 TU PPD intradermally) with documented wheal formation at placement 2, 3. Reading performed by trained personnel measuring transverse diameter of induration, not erythema 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.